Board of Directors
Mr. Mark Saldanha
Promoter and Managing Director
Mr. Mark Saldanha is the Chairman and Managing Director of Marksans. He set out with a vision to create a global pharmaceutical company. Under his able and dynamic leadership, Marksans has grown rapidly to attain newer milestones and the highest level of performance. He is the principal architect for the progress of the organization.
Mr. Mark Saldanha is a science graduate with more than two decades of experience across business and technical functions. He is well versed with the overall management of the company and possesses vast amount of hands-on experience in marketing, production and finance.
His business acumen, entrepreneurial zeal, organizational skills and managerial abilities have enabled Marksans to grow leaps and bounds and spread its wings across the globe.
Mrs. Sandra Saldanha
Mrs. Sandra Saldanha has a Master Degree in Arts (Sociology). She has vast experience in the field of Human Resource Management, Business Development, Projects and Supply Chain Management. Mrs. Saldanha is also a Director in Marksans Pharma (UK) Limited.
Mr. Varddhman Vikramaditya Jain
Mr. Varddhman Vikramaditya Jain is M. Pharm (Pharmaceuticals). He is a Pharmaceutical professional with technical background who has worked with various multinational organizations. He is specialized in the area of manufacturing, quality R&D, compliance & regulatory affairs both for API and finished dosage from manufacturing. In a carer span of 25 years, Mr. Jain has successfully handeled several regulatory inspection including SFDA, MHRA, PMDA Japan and WHO with good leadership and sound technical knowledge. He has given the organizations very sound systems which are capble of standing up to very tough regulatory inspections of recent years.
Mr. Seetharama Raju Buddharaju
Mr. Seetharama Raju Buddharaju is a Director of the company and has more than 35 years of experience in Sales Management, Marketing and Business Administration. He holds a B.Sc., a PGDBM and a PGDMSM. For over 22 years, he has successfully handled various senior sales management roles for Parke-Davis and Pfizer.
Mrs. Shailaja Vardhan
Mrs. Shailaja Vardhan, a seasoned communications professional has an impressive track record that extends over three decades. Throughout her career, she has made significant contributions to both multinational corporations and entrepreneurial organizations, assuming crucial responsibilities in the areas of brand architecture development, positioning strategies, go-to-market approach formulation, and the implementation of impactful communication initiatives to enhance brand reputation. Her expertise and achievements have earned her recognition as one of India's foremost corporate communications professionals. Currently, Shailaja Vardhan serves as the driving force behind the leadership communication at the Apollo Hospitals Group.
Mr. Digant Mahesh Parikh
Mr. Digant Mahesh Parikh is a Master of Business Administration in Finance. He has over 23 years of experience in diverse industries in areas of Corporate Finance, Strategic Planning and Business Set-up & Scale up. He is a visiting faculty at leading management schools for the subjects in the field of Corporate & Retail Finance and Banking.
Mr. Abhinna Sundar Mohanty
Mr. Abhinna Sundar Mohanty is an M.Sc. in Mathematics. He has 39 years of experience in the pharmaceutical industry. He started his career with Alembic and went on to build his career through every cadre in sales and marketing department of pharma industry. During his career, he was engaged in sales, marketing, business development and business strategy for over 27 years in pharma industry. He was instrumental in globalising branded business for pharma sector in most part of the world.
Dr. Sunny Sharma
Dr. Sunny Sharma is an MBA and MBBS. He is a Senior Managing Director of OrbiMed Asia. Previously, he was with Investor Growth Capital (IGC), the investment arm of Investor AB in North America, and before that with Easton Capital in New York. Earlier in his career, Dr. Sharma worked in the healthcare investment banking group of Lehman Brothers in London.